ENTEGRIS INC (1ENTG.MI) Fundamental Analysis & Valuation

BIT:1ENTG • US29362U1043

Current stock price

109.94 EUR
-3.06 (-2.71%)
Last:

This 1ENTG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. 1ENTG.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ENTG was profitable.
  • 1ENTG had a positive operating cash flow in the past year.
  • In the past 5 years 1ENTG has always been profitable.
  • 1ENTG had a positive operating cash flow in each of the past 5 years.
1ENTG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ENTG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • 1ENTG has a worse Return On Assets (3.43%) than 62.12% of its industry peers.
  • The Return On Equity of 1ENTG (7.41%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 4.75%, 1ENTG is doing worse than 62.12% of the companies in the same industry.
  • 1ENTG had an Average Return On Invested Capital over the past 3 years of 4.27%. This is significantly below the industry average of 14.50%.
  • The 3 year average ROIC (4.27%) for 1ENTG is below the current ROIC(4.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.43%
ROE 7.41%
ROIC 4.75%
ROA(3y)2.53%
ROA(5y)6.1%
ROE(3y)6.57%
ROE(5y)13%
ROIC(3y)4.27%
ROIC(5y)7.78%
1ENTG.MI Yearly ROA, ROE, ROIC1ENTG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of 1ENTG (8.95%) is comparable to the rest of the industry.
  • 1ENTG's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 15.55%, 1ENTG perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • 1ENTG's Operating Margin has improved in the last couple of years.
  • 1ENTG's Gross Margin of 44.89% is in line compared to the rest of the industry. 1ENTG outperforms 40.91% of its industry peers.
  • In the last couple of years the Gross Margin of 1ENTG has remained more or less at the same level.
Industry RankSector Rank
OM 15.55%
PM (TTM) 8.95%
GM 44.89%
OM growth 3Y-11.8%
OM growth 5Y1.63%
PM growth 3Y-20.23%
PM growth 5Y-10.83%
GM growth 3Y-0.16%
GM growth 5Y0.5%
1ENTG.MI Yearly Profit, Operating, Gross Margins1ENTG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. 1ENTG.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ENTG is destroying value.
  • The number of shares outstanding for 1ENTG has been increased compared to 1 year ago.
  • Compared to 5 years ago, 1ENTG has more shares outstanding
  • 1ENTG has a better debt/assets ratio than last year.
1ENTG.MI Yearly Shares Outstanding1ENTG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
1ENTG.MI Yearly Total Debt VS Total Assets1ENTG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • 1ENTG has an Altman-Z score of 3.57. This indicates that 1ENTG is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 3.57, 1ENTG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • 1ENTG has a debt to FCF ratio of 11.67. This is a negative value and a sign of low solvency as 1ENTG would need 11.67 years to pay back of all of its debts.
  • 1ENTG has a Debt to FCF ratio of 11.67. This is in the lower half of the industry: 1ENTG underperforms 66.67% of its industry peers.
  • 1ENTG has a Debt/Equity ratio of 0.99. This is a neutral value indicating 1ENTG is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.99, 1ENTG is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 11.67
Altman-Z 3.57
ROIC/WACC0.43
WACC10.94%
1ENTG.MI Yearly LT Debt VS Equity VS FCF1ENTG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • 1ENTG has a Current Ratio of 3.44. This indicates that 1ENTG is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of 1ENTG (3.44) is better than 72.73% of its industry peers.
  • 1ENTG has a Quick Ratio of 2.13. This indicates that 1ENTG is financially healthy and has no problem in meeting its short term obligations.
  • 1ENTG's Quick ratio of 2.13 is fine compared to the rest of the industry. 1ENTG outperforms 71.21% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 2.13
1ENTG.MI Yearly Current Assets VS Current Liabilites1ENTG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

3

3. 1ENTG.MI Growth Analysis

3.1 Past

  • The earnings per share for 1ENTG have decreased by -8.33% in the last year.
  • 1ENTG shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.68% yearly.
EPS 1Y (TTM)-8.33%
EPS 3Y-9.74%
EPS 5Y1.68%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.05%

3.2 Future

  • 1ENTG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.03% yearly.
  • 1ENTG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.01% yearly.
EPS Next Y20.14%
EPS Next 2Y23.63%
EPS Next 3Y19.32%
EPS Next 5Y18.03%
Revenue Next Year6.09%
Revenue Next 2Y7.48%
Revenue Next 3Y7.2%
Revenue Next 5Y8.01%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
1ENTG.MI Yearly Revenue VS Estimates1ENTG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
1ENTG.MI Yearly EPS VS Estimates1ENTG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

1

4. 1ENTG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 46.19, which means the current valuation is very expensive for 1ENTG.
  • 1ENTG's Price/Earnings ratio is in line with the industry average.
  • 1ENTG is valuated expensively when we compare the Price/Earnings ratio to 25.73, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 38.42, 1ENTG can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, 1ENTG is valued a bit more expensive than the industry average as 62.12% of the companies are valued more cheaply.
  • 1ENTG is valuated expensively when we compare the Price/Forward Earnings ratio to 23.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.19
Fwd PE 38.42
1ENTG.MI Price Earnings VS Forward Price Earnings1ENTG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ENTG is on the same level as its industry peers.
  • 1ENTG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 58.18
EV/EBITDA 25.65
1ENTG.MI Per share data1ENTG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ENTG does not grow enough to justify the current Price/Earnings ratio.
  • 1ENTG's earnings are expected to grow with 19.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.29
PEG (5Y)27.47
EPS Next 2Y23.63%
EPS Next 3Y19.32%

4

5. 1ENTG.MI Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.36%, 1ENTG is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.84, 1ENTG has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, 1ENTG's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

  • The dividend of 1ENTG has a limited annual growth rate of 4.63%.
Dividend Growth(5Y)4.63%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 21.08% of the earnings are spent on dividend by 1ENTG. This is a low number and sustainable payout ratio.
  • 1ENTG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.08%
EPS Next 2Y23.63%
EPS Next 3Y19.32%
1ENTG.MI Yearly Income VS Free CF VS Dividend1ENTG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M
1ENTG.MI Dividend Payout.1ENTG.MI Dividend Payout, showing the Payout Ratio.1ENTG.MI Dividend Payout.PayoutRetained Earnings

1ENTG.MI Fundamentals: All Metrics, Ratios and Statistics

ENTEGRIS INC

BIT:1ENTG (3/4/2026, 7:00:00 PM)

109.94

-3.06 (-2.71%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-05
Inst Owners114.39%
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap16.71B
Revenue(TTM)N/A
Net Income(TTM)288.44M
Analysts75.79
Price Target119.68 (8.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend0.35
Dividend Growth(5Y)4.63%
DP21.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.28%
Min EPS beat(2)-2.69%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)0.29%
Min EPS beat(4)-3.94%
Max EPS beat(4)5.65%
EPS beat(8)4
Avg EPS beat(8)1.73%
EPS beat(12)8
Avg EPS beat(12)5.46%
EPS beat(16)10
Avg EPS beat(16)3.35%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)2.48%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-4.03%
Max Revenue beat(4)2.48%
Revenue beat(8)3
Avg Revenue beat(8)-0.91%
Revenue beat(12)4
Avg Revenue beat(12)-0.91%
Revenue beat(16)6
Avg Revenue beat(16)-0.54%
PT rev (1m)16.98%
PT rev (3m)N/A
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.09%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 46.19
Fwd PE 38.42
P/S 5.97
P/FCF 58.18
P/OCF 28.32
P/B 4.95
P/tB N/A
EV/EBITDA 25.65
EPS(TTM)2.38
EY2.16%
EPS(NY)2.86
Fwd EY2.6%
FCF(TTM)1.89
FCFY1.72%
OCF(TTM)3.88
OCFY3.53%
SpS18.41
BVpS22.23
TBVpS-5.76
PEG (NY)2.29
PEG (5Y)27.47
Graham Number34.5
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 7.41%
ROCE 6.33%
ROIC 4.75%
ROICexc 5%
ROICexgc 14.39%
OM 15.55%
PM (TTM) 8.95%
GM 44.89%
FCFM 10.26%
ROA(3y)2.53%
ROA(5y)6.1%
ROE(3y)6.57%
ROE(5y)13%
ROIC(3y)4.27%
ROIC(5y)7.78%
ROICexc(3y)4.5%
ROICexc(5y)9.07%
ROICexgc(3y)14.12%
ROICexgc(5y)21.22%
ROCE(3y)5.69%
ROCE(5y)10.38%
ROICexgc growth 3Y-20.91%
ROICexgc growth 5Y-5.15%
ROICexc growth 3Y-32.38%
ROICexc growth 5Y-11.06%
OM growth 3Y-11.8%
OM growth 5Y1.63%
PM growth 3Y-20.23%
PM growth 5Y-10.83%
GM growth 3Y-0.16%
GM growth 5Y0.5%
F-Score7
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 11.67
Debt/EBITDA 4.36
Cap/Depr 90.77%
Cap/Sales 10.82%
Interest Coverage 2.58
Cash Conversion 76.76%
Profit Quality 114.68%
Current Ratio 3.44
Quick Ratio 2.13
Altman-Z 3.57
F-Score7
WACC10.94%
ROIC/WACC0.43
Cap/Depr(3y)122.77%
Cap/Depr(5y)123.45%
Cap/Sales(3y)12.3%
Cap/Sales(5y)10.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.33%
EPS 3Y-9.74%
EPS 5Y1.68%
EPS Q2Q%-16.67%
EPS Next Y20.14%
EPS Next 2Y23.63%
EPS Next 3Y19.32%
EPS Next 5Y18.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.05%
Revenue Next Year6.09%
Revenue Next 2Y7.48%
Revenue Next 3Y7.2%
Revenue Next 5Y8.01%
EBIT growth 1Y7.65%
EBIT growth 3Y-1.1%
EBIT growth 5Y17.17%
EBIT Next Year21.88%
EBIT Next 3Y14.37%
EBIT Next 5Y12.55%
FCF growth 1Y834.38%
FCF growth 3Y18.52%
FCF growth 5Y3.21%
OCF growth 1Y32.97%
OCF growth 3Y16.41%
OCF growth 5Y10.57%

ENTEGRIS INC / 1ENTG.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ENTEGRIS INC (1ENTG.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ENTG.MI.


Can you provide the valuation status for ENTEGRIS INC?

ChartMill assigns a valuation rating of 1 / 10 to ENTEGRIS INC (1ENTG.MI). This can be considered as Overvalued.


What is the profitability of 1ENTG stock?

ENTEGRIS INC (1ENTG.MI) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ENTEGRIS INC (1ENTG.MI) stock?

The Price/Earnings (PE) ratio for ENTEGRIS INC (1ENTG.MI) is 46.19 and the Price/Book (PB) ratio is 4.95.


What is the financial health of ENTEGRIS INC (1ENTG.MI) stock?

The financial health rating of ENTEGRIS INC (1ENTG.MI) is 4 / 10.